Koji Yada, Kenichi Ogiwara, Naruto Shimonishi, Yuto Nakajima, Tetsuhiro Soeda, Takehisa Kitazawa, Keiji Nogami. Emicizumab-mediated hemostatic function assessed by thrombin generation assay in an in vitro model of factor VIII-depleted thrombophilia plasma. International journal of hematology. 2024. 119. 2. 109-118
Masahiro Takeyama, Shoko Furukawa, Kenichi Ogiwara, Shinobu Tamura, Hitoshi Ohno, Satoshi Higasa, Naruto Shimonishi, Yuto Nakajima, Tomoko Onishi, Keiji Nogami. Coagulation potentials of plasma-derived factors VIIa and X mixture (Byclot® ) evaluated by global coagulation assay in patients with acquired haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia. 2024. 30. 1. 249-252
Kuniyoshi Mizumachi, Yuto Nakajima, Naruto Shimonishi, Shoko Furukawa, Kenichi Ogiwara, Masahiro Takeyama, Keiji Nogami. Hybrid human-porcine factor VIII proteins partially escape the inhibitory effects of anti-factor VIII inhibitor alloantibodies having A2 or C2 domain specificity. Haemophilia : the official journal of the World Federation of Hemophilia. 2024. 30. 1. 140-150
Naruto Shimonishi, Kana Sasai, Kenichi Ogiwara, Shoko Furukawa, Yuto Nakajima, Kuniyoshi Mizumachi, Koji Yada, Masahiro Takeyama, Midori Shima, Narumi Mizuno, et al. Longitudinal dynamic changes in factor VIII inhibitor titers in patients with hemophilia A and inhibitors receiving emicizumab prophylaxis. International journal of hematology. 2023. 118. 6. 690-698